Skip to main content

Table 2 Biochemical and immunological evaluation

From: Evolution of myocardial oedema and fibrosis in HIV infected persons after the initiation of antiretroviral therapy: a prospective cardiovascular magnetic resonance study

Parameter

Control group

HIV infected ART naïve

p valuea

HIV infected 9 months on ART

p valueb

 

ART naïve

(n = 22)

(n = 73)

(n = 73)

(Controls)

(Naïve)

(ART)

Serum creatinine (μmol/l)

72 ± 14

70 ± 14

0.6

82 ± 16

< 0.001

Estimated glomerular filtration rate (ml/min/1.73 m2)

111 ± 38

92 ± 22

0.03

83 ± 19

< 0.001

Fasting blood glucose (mmol/l)

5.0 ± 0.6

4.5 ± 0.6

< 0.001

4.7 ± 0.6

< 0.001

Haematocrit (%)

42 ± 4

38 ± 6

0.03

41 ± 5

< 0.001

Total fasting serum cholesterol (mmol/l)

4.3 (3.9 to 4.9)

3.4 (2.9 to 4.0)

< 0.001

3.5 (3.0 to 4.1)

0.1

Triglycerides (mmol/l)

0.9 (0.6 to 1.2)

0.8 (0.7 tot 1.2)

0.8

0.7 (0.6 to 1.2)

0.03

HDL cholesterol (mmol/l)

1.4 (1.2 to 1.5)

1.0 (0.8 to 1.3)

0.001

1.2 (1.0 to 1.4)

< 0.001

LDL cholesterol (mmol/l)

2.7 (2.0 to 3.1)

1.8 (1.5 to 2.4)

0.004

1.9 (1.6 to 2.4)

0.9

High sensitivity C-reactive protein (mg/l)

2.4 (1.1 to 9.2)

3.4 (0.8 to 13.7)

0.5

1.9 (0.5 to 7.5)

0.01

CD4 count (cells/μl)

–

289 (170 to 410)

–

378 (271 to 593)

< 0.001

CD8 count (cells/μl)

–

817 (584 to 1147)

–

624 (446 to 858)

< 0.001

CD4:CD8 ratio

–

0.35 (0.19 to 0.45)

–

0.60 (0.39 to 0.94)

< 0.001

HIV viral load (copies/ml)

 

78,279 (9796 to 336,900)

–

20* (20 to 36)

< 0.001

HIV viral load (log copies/ml)

–

4.9 (4.0 to 5.5)

–

1.3* (1.3 to 1.6)

< 0.001

  1. Bold values indicate p value of ≤ 0.05
  2. Continuous variables are mean ± standard deviation or median (interquartile range) unless otherwise specified
  3. HDL high density lipoprotein, LDL low density lipoprotein, HIV Human immunodeficiency virus
  4. aControls vs naïve
  5. bNaïve vs ART
  6. *20 copies/ml (log = 1.3) is the lower limit of measurement for our HIV-1 assay